Rage fusion proteins, formulations, and methods of use thereof

Details for Australian Patent Application No. 2007248784 (hide)

Owner TransTech Pharma, Inc.

Inventors Mjalli, Adnan M.M.; Benjamin, Eric J.; Webster, Jeffrey C.; Tian, Ye Edward; Rothlein, Robert

Agent Spruson & Ferguson

Pub. Number AU-A-2007248784

PCT Pub. Number WO2007/130302

Priority 60/798,455 05.05.06 US

Filing date 25 April 2007

Wipo publication date 15 November 2007

International Classifications

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/130302 Priority application(s): WO2007/130302

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007248790-Trajectory-based deep-brain stereotactic transcranial magnetic stimulation

2007248779-A colored article of manufacture and a process for its preparation